Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Parissa Tabrizian"'
Autor:
Constance M. Mobley, Maarouf Hoteit, Debra L. Sudan, David D. Lee, Thomas M. Fishbein, Carol A. Carney, Michael L. Kueht, Alan W. Hemming, Vatche G. Agopian, Karim J. Halazun, Federico Aucejo, Matthew H. Levine, Johnny C. Hong, Amit D. Tevar, Sander Florman, Joseph DiNorcia, Alan N. Langnas, James F. Markmann, Abbas Rana, Goran B. Klintmalm, Joohyun Kim, Elizabeth C. Verna, Richard Ruiz, C. Burcin Taner, Trevor L. Nydam, Beth Amundsen, Mindie H. Nguyen, Abhinav Humar, Ronald W. Busuttil, Neeta Vachharajani, Daniela Markovic, Parissa Tabrizian, Marc L. Melcher, Srinath Senguttuvan, William C. Chapman, Jennifer Berumen, R. Mark Ghobrial, Brandy Haydel, Michael A. Zimmerman, Christopher M. Jones
Publikováno v:
Annals of Surgery. 271:616-624
OBJECTIVE The aim of the study was to determine the rate, predictors, and impact of complete pathologic response (cPR) to pretransplant locoregional therapy (LRT) in a large, multicenter cohort of hepatocellular carcinoma (HCC) patients undergoing li
Autor:
Sander Florman, Myron Schwartz, Jean C. Emond, Benjamin Samstein, Fabrizio Michelassi, Ronald W. Busuttil, Parissa Tabrizian, Vatche G. Agopian, Robert S. Brown, Marc Najjar, Karim J. Halazun
Publikováno v:
Annals of surgery. 268(4)
OBJECTIVES European liver transplant (LT) centers have moved away from using the Milan Criteria (MC) for hepatocellular carcinoma (HCC) patient selection, turning to models including tumor biological indices, namely alpha-fetoprotein (AFP). We presen
Publikováno v:
Annals of Surgery. 261:947-955
We sought to determine the factors associated with survival after recurrence of hepatocellular cancer (HCC) after resection and the outcome of our prospectively applied treatment protocol.Very little is known about the prognosis of HCC that recurs af